First-half 2016 results

19/09/16

DOWNLOAD

Revenue for the first half of 2016: €5.7 million

18/07/16

DOWNLOAD

Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer

12/07/16

DOWNLOAD

Oncodesign is granted new patent protecting key molecules generated from its Nanocyclix technology platform for next generation kinase inhibitors

30/05/16

DOWNLOAD

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.